Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

In celebration of Canada’s 150th anniversary, Their Royal Highnesses, The Prince of Wales and The Duchess of Cornwall were in attendance for many festivities in Ottawa on July 1st.

Dr. Mohit Bhandari, a member of the SAC Executive committee,  a Professor in the Department of Surgery at McMaster University and a leader in the field of orthopedic surgery has […]

Volunteer of Distinction Award Form The Volunteer of Distinction Award is to honour an individual who has made an exceptional and sustained contribution to Osteoporosis Canada and has demonstrated outstanding […]

IMPACT REPORT 2017 “I thought my active lifestyle would insulate me from such things.” Colm MEET JOANNE & COLM When Joanne Kelly was diagnosed with osteoporosis in 2007, she wished […]

SCIENTIFIC ADVISORY COUNCIL We look to the best experts to inform our care guidelines for patients and care providers. Our Scientific Advisory Council (SAC) is made up of experts in […]

Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

Members of Osteoporosis Canada’s Scientific Advisory Council would like announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. Osteoporosis Canada established this award in 1993 […]

Today, most people consume too much protein at dinner and not enough at breakfast. In recent years, scientific studies have shown that a balanced consumption of protein throughout the day […]